These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 19486011)

  • 1. Improvement of radiation-induced healing delay by etanercept treatment in rat arteries.
    Sugiyama K; Yamaguchi M; Kuroda J; Takanashi M; Ishikawa Y; Fujii H; Ishii T; Esumi H
    Cancer Sci; 2009 Aug; 100(8):1550-5. PubMed ID: 19486011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutralization of interleukin-18 inhibits neointimal formation in a rat model of vascular injury.
    Maffia P; Grassia G; Di Meglio P; Carnuccio R; Berrino L; Garside P; Ianaro A; Ialenti A
    Circulation; 2006 Aug; 114(5):430-7. PubMed ID: 16864728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor necrosis factor-α inhibition improves endothelial function and decreases arterial stiffness in estrogen-deficient postmenopausal women.
    Moreau KL; Deane KD; Meditz AL; Kohrt WM
    Atherosclerosis; 2013 Oct; 230(2):390-6. PubMed ID: 24075772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Etanercept attenuates traumatic brain injury in rats by reducing early microglial expression of tumor necrosis factor-α.
    Chio CC; Chang CH; Wang CC; Cheong CU; Chao CM; Cheng BC; Yang CZ; Chang CP
    BMC Neurosci; 2013 Mar; 14():33. PubMed ID: 23496862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis factor antagonism with etanercept improves systemic endothelial vasoreactivity in patients with advanced heart failure.
    Fichtlscherer S; Rössig L; Breuer S; Vasa M; Dimmeler S; Zeiher AM
    Circulation; 2001 Dec; 104(25):3023-5. PubMed ID: 11748093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor-α enhances microvascular tone and reduces blood flow in the cochlea via enhanced sphingosine-1-phosphate signaling.
    Scherer EQ; Yang J; Canis M; Reimann K; Ivanov K; Diehl CD; Backx PH; Wier WG; Strieth S; Wangemann P; Voigtlaender-Bolz J; Lidington D; Bolz SS
    Stroke; 2010 Nov; 41(11):2618-24. PubMed ID: 20930159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasculoprotective effects of anti-tumor necrosis factor-alpha treatment in aging.
    Csiszar A; Labinskyy N; Smith K; Rivera A; Orosz Z; Ungvari Z
    Am J Pathol; 2007 Jan; 170(1):388-98. PubMed ID: 17200210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective estrogen receptor modulator idoxifene inhibits smooth muscle cell proliferation, enhances reendothelialization, and inhibits neointimal formation in vivo after vascular injury.
    Yue TL; Vickery-Clark L; Louden CS; Gu JL; Ma XL; Narayanan PK; Li X; Chen J; Storer B; Willette R; Gossett KA; Ohlstein EH
    Circulation; 2000 Nov; 102(19 Suppl 3):III281-8. PubMed ID: 11082402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial Myocyte Enhancer Factor 2c Inhibits Migration of Smooth Muscle Cells Through Fenestrations in the Internal Elastic Lamina.
    Lu YW; Lowery AM; Sun LY; Singer HA; Dai G; Adam AP; Vincent PA; Schwarz JJ
    Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1380-1390. PubMed ID: 28473437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretreatment with the tumor nerosis factor-alpha blocker etanercept attenuated ischemia-reperfusion renal injury.
    Choi DE; Jeong JY; Lim BJ; Na KR; Shin YT; Lee KW
    Transplant Proc; 2009 Nov; 41(9):3590-6. PubMed ID: 19917350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular wound healing and neointima formation induced by perivascular electric injury in mice.
    Carmeliet P; Moons L; Stassen JM; De Mol M; Bouché A; van den Oord JJ; Kockx M; Collen D
    Am J Pathol; 1997 Feb; 150(2):761-76. PubMed ID: 9033288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor-α antagonist reduces apoptosis of neurons and oligodendroglia in rat spinal cord injury.
    Chen KB; Uchida K; Nakajima H; Yayama T; Hirai T; Watanabe S; Guerrero AR; Kobayashi S; Ma WY; Liu SY; Baba H
    Spine (Phila Pa 1976); 2011 Aug; 36(17):1350-8. PubMed ID: 21224756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver X receptor agonists suppress vascular smooth muscle cell proliferation and inhibit neointima formation in balloon-injured rat carotid arteries.
    Blaschke F; Leppanen O; Takata Y; Caglayan E; Liu J; Fishbein MC; Kappert K; Nakayama KI; Collins AR; Fleck E; Hsueh WA; Law RE; Bruemmer D
    Circ Res; 2004 Dec; 95(12):e110-23. PubMed ID: 15539633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural recovery of small arteries following clamp injury: a light and electron microscopic investigation in the rat.
    Jackiewicz TA; McGeachie JK; Tennant M
    Microsurgery; 1996; 17(12):674-80. PubMed ID: 9588712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble guanylate cyclase alpha(1) and beta(1) gene transfer increases NO responsiveness and reduces neointima formation after balloon injury in rats via antiproliferative and antimigratory effects.
    Sinnaeve P; Chiche JD; Nong Z; Varenne O; Van Pelt N; Gillijns H; Collen D; Bloch KD; Janssens S
    Circ Res; 2001 Jan; 88(1):103-9. PubMed ID: 11139481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of neointima formation by taurine ingestion after carotid balloon injury.
    Murakami S; Sakurai T; Toda Y; Morito A; Sakono M; Fukuda N
    Vascul Pharmacol; 2010; 53(3-4):177-84. PubMed ID: 20674770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smooth muscle DNA replication in response to angiotensin II is regulated differently in the neointima and media at different times after balloon injury in the rat carotid artery. Role of AT1 receptor expression.
    deBlois D; Viswanathan M; Su JE; Clowes AW; Saavedra JM; Schwartz SM
    Arterioscler Thromb Vasc Biol; 1996 Sep; 16(9):1130-7. PubMed ID: 8792766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 20-Hydroxyeicosatetraenoic acid inhibition attenuates balloon injury-induced neointima formation and vascular remodeling in rat carotid arteries.
    Orozco LD; Liu H; Perkins E; Johnson DA; Chen BB; Fan F; Baker RC; Roman RJ
    J Pharmacol Exp Ther; 2013 Jul; 346(1):67-74. PubMed ID: 23658377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-tumor necrosis factor-α therapy and changes of flow-mediated vasodilatation in psoriatic and rheumatoid arthritis patients.
    Mazzoccoli G; Notarsanto I; de Pinto GD; Dagostino MP; De Cata A; D'Alessandro G; Tarquini R; Vendemiale G
    Intern Emerg Med; 2010 Dec; 5(6):495-500. PubMed ID: 20845087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to anti-tumour necrosis factor alpha blockade is associated with reduction of carotid intima-media thickness in patients with active rheumatoid arthritis.
    Del Porto F; Laganà B; Lai S; Nofroni I; Tinti F; Vitale M; Podestà E; Mitterhofer AP; D'Amelio R
    Rheumatology (Oxford); 2007 Jul; 46(7):1111-5. PubMed ID: 17449484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.